Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Free Report) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totalling 108,500 shares, a drop of 18.5% from the December 15th total of 133,100 shares. Currently, 7.9% of the company’s shares are sold short. Based on an average trading volume of 24,000 shares, the short-interest ratio is currently 4.5 days.
Alaunos Therapeutics Price Performance
TCRT traded up $0.05 during trading on Friday, hitting $1.78. The company’s stock had a trading volume of 18,974 shares, compared to its average volume of 24,775. Alaunos Therapeutics has a twelve month low of $1.63 and a twelve month high of $32.85. The stock’s fifty day moving average price is $2.09 and its 200-day moving average price is $2.80.
Alaunos Therapeutics Company Profile
Recommended Stories
- Five stocks we like better than Alaunos Therapeutics
- Conference Calls and Individual Investors
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Alaunos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alaunos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.